Home » Stocks » AVNS

Avanos Medical, Inc. (AVNS)

Stock Price: $42.99 USD 0.50 (1.18%)
Updated November 23, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 2.06B
Revenue (ttm) 719.60M
Net Income (ttm) 13.90M
Shares Out 47.83M
EPS (ttm) 0.29
PE Ratio 148.24
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $42.99
Previous Close $42.49
Change ($) 0.50
Change (%) 1.18%
Day's Open 42.60
Day's Range 42.60 - 43.62
Day's Volume 245,478
52-Week Range 19.46 - 44.85

More Stats

Market Cap 2.06B
Enterprise Value 2.20B
Earnings Date (est) Mar 2, 2021
Ex-Dividend Date n/a
Shares Outstanding 47.83M
Float 46.99M
EPS (basic) 0.30
EPS (diluted) 0.29
FCF / Share -0.62
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.67%
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.97M
Short Ratio 8.46
Short % of Float 4.18%
Beta 1.01
PE Ratio 148.24
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.86
PB Ratio 1.58
Revenue 719.60M
Operating Income 6.40M
Net Income 13.90M
Free Cash Flow -29.70M
Net Cash -140.20M
Net Cash / Share -2.93
Gross Margin 55.89%
Operating Margin 0.89%
Profit Margin 1.90%
FCF Margin -4.13%
ROA 0.44%
ROE 1.09%
ROIC -0.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (7)

Buy 3
Overweight 0
Hold 3
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$43.60*
(1.42% upside)
Low
36.0
Current: $42.99
High
48.0
Target: 43.60
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue6986526125665091,6721,6781,6841,660
Revenue Growth6.94%6.65%8.02%11.24%-69.56%-0.32%-0.39%1.45%-
Gross Profit402391337297258549612603591
Operating Income-34.608.70-23.00-87.40-12090.50223227208
Net Income-45.9057.5079.3039.80-42627.10155153142
Shares Outstanding47.9347.4346.8446.6746.6146.5446.54--
Earnings Per Share-0.961.221.690.85-9.150.583.323.28-
EPS Growth--27.81%98.82%---82.53%1.22%--
Operating Cash Flow-74.50-14614418997.60148224203140
Capital Expenditures-50.60-49.10-43.10-25.90-62.60-70.70-48.70-40.30-35.80
Free Cash Flow-125-19510116335.0077.20175162104
Cash & Equivalents20538522011413014944.1047.90-
Total Debt32524858157957862711.9075.90-
Net Cash / Debt-120137-361-465-449-47832.20-28.00-
Assets1,8001,8332,1962,0722,0002,5182,4842,534-
Liabilities5345369819699451,027405479-
Book Value1,2651,2971,2151,1031,0551,4912,0792,056-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avanos Medical, Inc.
Country United States
Employees 4,700
CEO Joseph F. Woody

Stock Information

Ticker Symbol AVNS
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: AVNS

Description

Avanos Medical operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.